A spokesman for the Leeds-based company said the purchase of award-winning training provider Ubi-Tech (3R) complements the services offered by Bailie Group’s existing CDS defence and security business.
The statement added: “Established in 2012, Redditch-based Ubi-Tech (3R) has amassed a renowned reputation for telecommunications-industry training. The company was founded by former members of the British armed forces, and all the firm’s instructors have served in the military.”
Ubi-Tech (3R) and CDS DS will both remain separate entities following the completion of the deal, which is for an undisclosed sum. The Bailie Group is aiming for 60% growth over the next three years.
A spokesman added: “This is the first acquisition specifically for CDS DS.”
Bailie Group’s CEO Fergus Bailie said: “CDS DS is no stranger to high-profile programmes of work for UK military operations, and in recent times we have collaborated with Ubi-Tech on a number of projects – notably for the British Army.
“The more we’ve worked alongside each other, the clearer our synergies have become – particularly when it comes to the design, analysis and delivery of specialist training.
“While a significant proportion of Bailie Group’s growth has been organic throughout our 158-year history, we recognise the value of strategic acquisitions too. While operationally it’s therefore ‘business as usual’ for Ubi-Tech (3R) and CDS DS, we believe the move has unlocked a wealth of potential for both brands.”
He added: “Everything comes back to our search for the best people in the industry; whether they become a true part of our team, or we work together as partners.
“The experience and reputation of Ubi-Tech (3R) is world-class, so the acquisition really does bolster our current roster of capabilities.”
With a portfolio of communications and consultancies throughout the UK, Bailie Group currently employs 375 staff, and aims to bring 75 extra staff into the company by the end of 2022.
CDS DS specialises in the development of defence and security clients’ operational effectiveness and risk reduction.